Serina Therapeutics, Inc. (SER): Depreciation & Amortization

Annual figures by period end, from SEC filings.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the year ended 2020-12-31 (for example after a spin-off or a discontinued operation), while the year before it was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

$73.0K

Year ended 2025-12-31

$76.0K

Trailing 12 months to 2026-06-30

-36.4%

5-year compound annual growth

2018-12-31 Depreciation & Amortization (USD) 2025-12-31

Period ended	Depreciation & Amortization	Change YoY	Source filing
2025-12-31	$73.0K	-62.4%	2026-03-25, From 2025-01-01
2024-12-31	$194.0K	+115.6%	2026-03-25, From 2024-01-01
2023-12-31	$90.0K	n/a	2025-03-24, From 2023-01-01
No annual figure between 2020-12-31 and 2023-12-31.
2020-12-31	$699.0K	n/c	2022-03-29, From 2020-01-01
2019-12-31	$393.0K	+577.6%	2021-03-31, From 2019-01-01
2018-12-31	$58.0K	n/a	2020-03-31, From 2018-01-01

Depreciation & Amortization at similar companies

Companies with the same SEC industry code (Pharmaceutical Preparations), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

Company	Year ended	Depreciation & Amortization	Change YoY
Serina Therapeutics, Inc. (SER)	2025-12-31	$73.0K	-62.4%
Lisata Therapeutics, Inc. (LSTA)	2025-12-31	$146.0K	-16.1%
Actinium Pharmaceuticals, Inc. (ATNM)	2025-12-31	$173.0K	-12.2%
Incannex Healthcare Inc. (IXHL)	2025-06-30	$246.0K	+138.8%
Connect Biopharma Holdings Ltd (CNTB)	2025-12-31	$704.0K	+6.7%
Avalo Therapeutics, Inc. (AVTX)	2025-12-31	$344.0K	+103.6%
HCW Biologics Inc. (HCWB)	2025-12-31	$1.04M	-12.0%
Vyome Holdings, Inc (HIND)	2025-12-31	$12.0K	-30.9%
Allarity Therapeutics, Inc. (ALLR)	2024-12-31	$9.0K	-75.7%

Compare SER, LSTA, ATNM, IXHL side by side · Screen every company in Pharmaceutical Preparations ↗